Mepolizumab-Related Blood Eosinophil Decreases Are Associated with Clinical Remission in Severe Asthmatic Patients: A Real-World Study
<b>Background</b>: Mepolizumab is an effective treatment for severe eosinophilic asthma, leading to a depletion of blood eosinophil levels, the clinical relevance of which remains unclear. <b>Objective</b>: The aim of this study was to assess the relationship between mepolizumab-induced blood eosino...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI AG
2025-07-01
|
| Schriftenreihe: | Antibodies |
| Schlagworte: | |
| Online-Zugang: | https://www.mdpi.com/2073-4468/14/3/61 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|